Dale Klein
Family Medicine · Mandan, NDNPI 1215048277
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 224 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 19.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $625 and has fallen 96.0% since, to $25 in 2024. Among family medicine clinicians in ND with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 224 payments — averaging $13.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$601
- Amgen$432
- AstraZeneca$321
- AbbVie$273
- Pfizer$271
- Astellas Pharma US Inc$184
- plus $958 from 13 others
What the payments were for
- Food & beverage$3,040100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 60 | $601 |
| Amgen | 34 | $432 |
| AstraZeneca | 8 | $321 |
| AbbVie(2 entities) | 21 | $273 |
| Pfizer | 19 | $271 |
| Astellas Pharma US Inc | 12 | $184 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $168 |
| Novo Nordisk | 21 | $153 |
| Boehringer Ingelheim | 10 | $142 |
| Merck | 8 | $133 |
| Novartis | 5 | $81 |
| Daiichi Sankyo Inc. | 4 | $81 |
| Johnson & Johnson | 5 | $68 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $55 |
| Phadia US Inc. | 1 | $21 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Lexicon Pharmaceuticals, Inc. | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $12 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$249
- SYMBICORT$249
- BREZTRI AEROSPHERE$121
How this compares
$3,040 in reported general payments places this provider in the 90th percentile of 337 family medicine providers in North Dakota.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 34 | $32,826 |
| EliquisApixaban | 27 | $26,843 |
| TrulicityDulaglutide | 16 | $21,925 |
| MounjaroTirzepatide | 19 | $19,687 |
| XareltoRivaroxaban | 22 | $15,363 |
| FarxigaDapagliflozin Propanediol | 25 | $14,686 |
| Breo ElliptaFluticasone/Vilanterol | 14 | $5,315 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 21 | $3,281 |
| Tamsulosin Hcl | 102 | $2,147 |
| Metoprolol Succinate | 90 | $2,006 |
| Atorvastatin Calcium | 161 | $1,952 |
| Rosuvastatin Calcium | 126 | $1,672 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $1,256 |
| Omeprazole | 102 | $1,148 |
| Duloxetine Hcl | 16 | $1,080 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $601 | $41,61335 claims |
| Boehringer IngelheimJardiance | $142 | $32,82634 claims |
| PfizerEliquis | $271 | $26,84327 claims |
| Johnson & JohnsonXarelto | $68 | $15,36322 claims |
| AstraZenecaFarxiga | $321 | $14,68625 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 337 family medicine providers in North Dakota.
Other family medicine in Mandan
- Thomas ThorsonMandan$241K
- Anthony JohnsonMandan$7K
- Gretchen Belzer CurlMandan$3K
- Meghan HendricksonMandan$3K
- Sadaf YousufMandan$1K
- Andrew DockterMandan$983
- Richard VetterWest Fargo$294K
- Gregory GreekGrand Forks$216K
- Katherine NeubauerWest Fargo$160K
- Spencer BerryFargo$81K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.